Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LT-0001
- Development stage
- Preclinical
- Lead developer
- LTT Bio-Pharma
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
LT-0001 is a preclinical-stage drug candidate developed by LTT Bio-Pharma, utilizing a specialized Drug Delivery System (DDS) based on stealth nanoparticles. This technology is designed to encapsulate small molecule therapeutics within nanocarriers that are modified to evade the reticuloendothelial system (RES), thereby prolonging systemic circulation and enhancing the delivery of the active pharmaceutical ingredient to target tissues. By employing "stealth" properties—typically achieved through surface modifications like PEGylation—LT-0001 aims to optimize the pharmacokinetic profile of small molecules, potentially increasing efficacy while reducing systemic toxicity and off-target effects. The platform represents LTT Bio-Pharma's core expertise in lipo-technology and advanced nanoparticle formulation.
- Other names
- Drug delivery systemstealth nanoparticles
Beyond the preview
Go deeper on LT-0001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LT-0001.